-
81
Combination of Anti-programmed Cell Death Protein 1 and Antiangiogenesis Displaying a Response Disparity between Pulmonary and Nonpulmonary Metastases
Published 2023-10-01Subjects: “…vascular endothelial growth factor-targeted therapy…”
Get full text
Article -
82
Neratinib and the Role of Anti‐HER2 Therapy in Salivary Duct Carcinoma
Published 2025-01-01Subjects: Get full text
Article -
83
Efficacy and safety of gut microbiome-targeted treatment in patients with depression: a systematic review and meta-analysis
Published 2025-01-01Subjects: Get full text
Article -
84
Molecular mechanisms of renal cell carcinoma metastasis and potential targets for therapy
Published 2025-01-01Subjects: Get full text
Article -
85
IDH Mutant Cholangiocarcinoma: Pathogenesis, Management, and Future Therapies
Published 2025-01-01Subjects: Get full text
Article -
86
-
87
Exploiting somatic oncogenic driver alterations in a patient with Li-Fraumeni syndrome– paving the path towards precision medicine: a case report
Published 2025-01-01Subjects: Get full text
Article -
88
-
89
Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective
Published 2025-01-01Subjects: Get full text
Article -
90
Targeted therapeutic strategies for Nectin-4 in breast cancer: Recent advances and future prospects
Published 2025-02-01Subjects: Get full text
Article -
91
-
92
RNA structure in alternative splicing regulation: from mechanism to therapy
Published 2024-07-01Subjects: Get full text
Article -
93
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
Published 2025-01-01Subjects: Get full text
Article -
94
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
Published 2023-04-01Subjects: Get full text
Article -
95
-
96
The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies
Published 2025-12-01Subjects: Get full text
Article -
97
Monitoring and management of adverse effects associated with trastuzumab deruxtecan: a UAE-specific consensus
Published 2025-01-01Subjects: Get full text
Article -
98
KEAP1 mutations as key crucial prognostic biomarkers for resistance to KRAS-G12C inhibitors
Published 2025-01-01Subjects: Get full text
Article -
99
-
100
Implications of noncoding RNAs for cancer therapy: Are we aiming at the right targets?
Published 2025-01-01Subjects: Get full text
Article